Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Blavatnik Fund for Innovation at Yale University
AddedFeb 18, 2024
UpdatedJun 28, 2026
Blavatnik Fund for Innovation at Yale University

Blavatnik Fund for Innovation at Yale University

Facilitating successful development of high-impact biomedical products from innovative life science research.

HQ
New Haven, CT, US
Founded
2016
Overview
Compare
Employees

The Blavatnik Fund for Innovation at Yale University was established to bridge the gap between early-stage life science research and the successful development of high-impact biomedical products. Its core mission is to accelerate the translation of innovative biomedical discoveries into viable commercial products that can improve human health. The fund provides financial support, resources, and expertise to Yale researchers, focusing on high-potential projects in the biomedical field.

Notable affiliated individuals include Len Blavatnik, whose philanthropic contributions made the fund possible. Key achievements of the fund include advancing numerous promising biomedical projects from concept to commercialization, thereby enhancing Yale's impact on global health. The fund has significantly contributed to fostering a robust ecosystem for life science innovation at Yale, driving forward groundbreaking research with real-world applications.

Quick Facts

When was Blavatnik Fund for Innovation at Yale University founded?

Blavatnik Fund for Innovation at Yale University was founded in 2016.

Where is Blavatnik Fund for Innovation at Yale University's headquarters located?

Blavatnik Fund for Innovation at Yale University's headquarters is located in New Haven, CT, US.

How many employees does Blavatnik Fund for Innovation at Yale University have?

Blavatnik Fund for Innovation at Yale University has 50 employees as of Feb 10, 2024.

Classification

Technology
  • Biotech
Customer
  • Non-Profit
Main Product
  • Biomedical Products
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 9 more industry codes
NAICS
  • 513200Software Publishers
  • 610000Educational Services
  • 510000Information
  • 513000Publishing Industries
  • 611000Educational Services
  • 513210Software Publishers
SIC
  • 8200Educational Services
  • 8290Schools And Educational Services, Not Elsewhere Classified
  • 7372Prepackaged Software